共 49 条
- [41] Semi-quantitative cerebral blood flow parameters derived from non-invasive [15O]H2O PET studies JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 (01): : 163 - 172
- [44] Use of Non-invasive Parameters and Machine-Learning Algorithms for Predicting Future Risk of Type 2 Diabetes: A Retrospective Cohort Study of Health Data From Kuwait FRONTIERS IN ENDOCRINOLOGY, 2019, 10
- [48] Adaptive Design Single Center Phosphodiesterase Type 4 (PDE4) Inhibitor - Ibudilast (MN-166-ALS-1201) Phase 1b/2a Clinical Trial Double-Blind (DB) with Open Label Extensions (OLE) [NCT02238626 ] for Amyotrophic Lateral Sclerosis (ALS) Patients [1] Not Requiring Non-Invasive Ventilation (no-NIV) up to 5 Years (Early Cohort-EC) and [2] Requiring Non-Invasive Ventilation (NIV) up to 10 Years(Advanced NIV Cohort-ANC) from Disease Onset - Behavior of Creatinine as a Biomarker in Short Clinical Trials NEUROLOGY, 2016, 86
- [49] Adaptive Design Single Center Phosphodiesterase Type 4 (PDE4) Inhibitor - Ibudilast (MN-166-ALS-1201) Phase 1b / 2a Clinical Trial Double - Blind (DB) with Open Label Extension (OLE) [NCT02238626] for Amyotrophic Lateral Sclerosis (ALS) Patients [1] Not Requiring Non-Invasive Ventilation (no NIV) up to 5 years (Early Cohort - EC) and [2] Requiring Non-Invasive Ventilation (NIV) up to 10 years (Advanced NIV Cohort - ANC) from Disease Onset - Report of Clinical Trial DB, OLE and Post-Treatment Cessation Epochs - Per-Protocol (PP) Treatment Completion Associated with Improved Survival and Post Treatment Cessation Loss of Muscle Strength NEUROLOGY, 2017, 88